SpeakSuite

Company Overview

Snapshot

Founded in January 2015 by Bentzi Treger and Raphi Nassi, SpeakSuite operated with 11–50 employees. The company raised a total of $4.08 million across 7 funding rounds from 4 investors.

Business overview

SpeakSuite is a speech therapy platform that leverages sound-recognition technology to assist children with articulation and generalization challenges. Developed by speech-language pathologists, sound-recognition experts, and software engineers, its core product offers personalized articulation goals, adapting target sounds and complexity based on phonemic context. The platform provides a fun at-home game for clients, which sends insights, data, and practice notes directly to speech-language pathologists (SLPs). SpeakSuite serves the digital healthcare market, focusing on digital therapeutics and mobile applications, and operates within the Health Tech & Life Sciences sector.

Strategic signal

In July 2024, SpeakSuite ceased operations, indicating a significant shift in its market presence and future trajectory. This event signals to investors and innovation teams that the company is no longer an active player in the digital speech therapy sector, potentially opening opportunities for competitors or highlighting challenges in the market for similar solutions.

Company Intelligence Q&A

What is SpeakSuite's primary focus?

SpeakSuite focuses on providing a speech therapy platform designed to help children with articulation and generalization, utilizing sound-recognition technology and personalized practice goals.

When was SpeakSuite founded and by whom?

SpeakSuite was founded in January 2015 by co-founders Bentzi Treger and Raphi Nassi.

What was the company's operational status in July 2024?

In July 2024, SpeakSuite ceased to operate, resulting in its current non-active status.

Which investors participated in SpeakSuite's January 2021 funding round?

In January 2021, SpeakSuite received investment from Maccabi Health Fund and MalamTeam.